stockrowTeva Pharmaceutical Industries Ltd.
TEVA Healthcare Drug Manufacturers Specialty & Generic
Teva Pharmaceutical Industries Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $17.3 billion, up 4.32% from fiscal 2024.
- Revenue
- −1.90%
- EPS
- −47.2%
- Free cash flow
- −30.3%
- Total debt
- −0.43%
Quarter to September 2026, against a year earlier
Follow TEVA
Alert me
Teva Pharmaceutical Industries Ltd. (TEVA) Operating margin
Teva Pharmaceutical Industries Ltd.'s operating margin over the twelve months to 30 September 2026 was 7.84%, down 4.7 percentage points from fiscal 2025 (12.5%). Over the past ten years it has ranged from −78.1% (fiscal 2017) to 17.1% (fiscal 2015); the current reading is higher than 91% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 12.5% | 6.59 |
| FY2024 | 5.91% | 3.18 |
| FY2023 | 2.73% | 17.45 |
| FY2022 | −14.7% | (25.52) |
| FY2021 | 10.8% | 32.24 |
| FY2020 | −21.4% | (18.81) |
| FY2019 | −2.63% | (10.24) |
| FY2018 | 7.61% | 85.72 |
| FY2017 | −78.1% | (87.94) |
| FY2016 | 9.83% | (7.23) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 16.3% | 18.28 |
| Jun 2026 | −2.03% | (18.40) |
| Mar 2026 | 16.4% | 14.93 |
| Dec 2025 | 1.44% | (18.25) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| UTHR United Therapeutics Corporation compare | 41.5% |
| ZTS Zoetis Inc. compare | 37.1% |
| NBIX Neurocrine Biosciences, Inc. compare | 24.0% |
| HLN Haleon PLC Sponsored ADR compare | 17.9% |
| TAK Takeda Pharmaceutical Co. compare | 11.6% |
| RDY Dr. Reddy's Laboratories Ltd compare | 9.20% |
| TEVA Teva Pharmaceutical Industries Ltd. | 7.84% |
| ELAN Elanco Animal Health Incorporated compare | 1.61% |
| VTRS Viatris Inc. compare | −0.03% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on TEVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement